Ensysce Biosciences ENSC
NASDAQ ENSC
$0.47 -0.04 (-7.84%)
At close: Oct 23, 2026 · 4:00 PM EDT

Ensysce Biosciences (ENSC) Sale and Maturity of Investments (2018 - 2020)

Updated

Analysis

Ensysce Biosciences (ENSC) Sale and Maturity of Investments (2018 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Ensysce Biosciences 1.20 Mn -10.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 559,681.00
Sep 30, 2020 40,000.00
Jun 30, 2020 48.18 Mn
Mar 31, 2020 136.32 Mn
Dec 31, 2019 11.80 Mn
Sep 30, 2019 144,000.00
Jun 30, 2019 328,000.00
Mar 31, 2019 151,204.00
Dec 31, 2018 362,773.00
Sep 30, 2018 142,560.00
Jun 30, 2018 271,834.00
Mar 31, 2018 61,420.00
API Access

Ensysce Biosciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ENSC&period=max&api_key=YOUR_API_KEY